Results 91 to 100 of about 19,870 (257)

Study of the Efficacy of Autologous Cell Therapy in Dilated Cardiomyopathy [PDF]

Background: Dilated cardiomyopathy (DCM) is one of the main causes of heart failure induction all over the world. In non-clinical trial many authors have demonstrated safety and effectiveness of autologous mesenchymal stem cells (MSCs).
Meruyert Latipbayeva, Bulat Kupenov, Almas Tolegenuly, Manarbek Askarov, Gulzi Kussaiynkhan, Abay Baigenzhin, Aizhan Akhayeva, Dinara Zakarina, Aikumis Mansharipova, Telman Seisembekov   +9 more
core   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Histopathology of familial versus nonfamilial dilated cardiomyopathy [PDF]

, 1993
Idiopathic dilated cardiomyopathy is most likely a heterogenous group of diseases characterized by ventricular dilatation and dysfunction. Approximately 20% of patients with idiopathic dilated cardiomyopathy have familial disease, which may be inapparent
Miller, Fletcher A., Michels, Virginia V., Rodeheffer, Richard J., Tazelaar, Henry D., Moll, Patricia Peyser, Driscoll, David J., Burnett, Jr. , John C., Jamil Tajik, A.   +7 more
core   +1 more source

Dilated Cardiomyopathy [PDF]

Circulation: Arrhythmia and Electrophysiology, 2013
Neal K, Lakdawala, Jeffery R, Winterfield, Birgit H, Funke   +2 more
openaire   +2 more sources

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

EFFECT OF BETA-BLOCKERS AND STUDY OF AGGREGATiVE ACTIVITY OF THROMBOCYTES IN PATiENTS WITH DILATED CARDIOMYOPATHY

Acta Biomedica Scientifica, 2012
The aim. was to study peculiarities of ischemic and idiopathic dilated cardiomyopathy and. aggregative activity of thrombocytes and. also the response to the therapy by beta-blockers (Atenolol and Bisoprolol). Material and.
P. N. Isakhanova, Yu. N. Ziyaev
doaj  

Bioinformatics identifies key genes and potential drugs for energy metabolism disorders in heart failure with dilated cardiomyopathy

Frontiers in Pharmacology
Background: Dysfunction in myocardial energy metabolism plays a vital role in the pathological process of Dilated Cardiomyopathy (DCM). However, the precise mechanisms remain unclear.
Haixia Wang, Peifeng Cai, Xiaohan Yu, Shiqi Li, Wei Zhu, Wei Zhu, Yuntao Liu, Yuntao Liu, Dawei Wang, Dawei Wang   +9 more
doaj   +1 more source

Tafazzin gene mutations are uncommon causes of dilated cardiomyopathy in adults

Cardiogenetics, 2011
Barth syndrome is an X-linked genetic condition featuring neutropenia, skeletal myopathy, and dilated cardiomyopathy in boys due to tafazzin (TAZ) mutations.
Matthew Taylor, Dobromir Slavov, Ernesto Salcedo, Xiao Zhu, Deborah Ferguson, Jean Jirikowic, Andrea Di Lenarda, Gianfranco Sinagra, Luisa Mestroni   +8 more
doaj   +1 more source

Dilated cardiomyopathy

, 2018
Dilated cardiomyopathy (DCM) is defined by the presence of LV dilatation and systolic dysfunction in the absence of significant CAD or an abnormal loading condition sufficient to cause global systolic impairment.
Maestrini, Viviana, Masci, Pier Giorgio, Kwon, Deborah   +2 more
core   +1 more source

Cardiovascular Immunology Research in Wuhan Union Hospital: Over the Past 25 years

Cardiovascular Innovations and Applications, 2017
Cardiovascular immunology research in Wuhan Union Hospital began in 1991. Anti-heart antibodies in dilated cardiomyopathy and acute viral myocarditis began to be reported from 1993.
Yuhua Liao, Yiyi Wang
doaj   +1 more source